Forma Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FMTX and buy or sell other stocks, ETFs, and their options commission-free!About FMTX
Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer.
CEOFrank D. Lee, MBA
CEOFrank D. Lee, MBA
Employees—
Employees—
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2011
Founded2011
Employees—
Employees—
FMTX Key Statistics
Market cap957.53M
Market cap957.53M
Price-Earnings ratio-5.00
Price-Earnings ratio-5.00
Dividend yield—
Dividend yield—
Average volume710.37K
Average volume710.37K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$20.68
52 Week high$20.68
52 Week low$4.95
52 Week low$4.95
Stock Snapshot
Forma Therapeutics(FMTX) stock is priced at $20.01, giving the company a market capitalization of 957.53M. It carries a P/E multiple of -5.00.
Forma Therapeutics(FMTX) stock opened on 2025-12-07 at —. The price climbed to — and dipped to —.
Forma Therapeutics(FMTX) shares are trading with a volume of 0, against a daily average of 710.37K.
During the past year, Forma Therapeutics(FMTX) stock moved between $4.95 at its lowest and $20.68 at its peak.
During the past year, Forma Therapeutics(FMTX) stock moved between $4.95 at its lowest and $20.68 at its peak.
People also own
Based on the portfolios of people who own FMTX. This list is generated using Robinhood data, and it’s not a recommendation.